Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome
Kandai Nozu, Yutaka Takaoka, Hirofumi Kai, Minoru Takasato, Kensuke Yabuuchi, Tomohiko Yamamura, Tomoko Horinouchi, Nana Sakakibara, Takeshi Ninchoji, China Nagano, Kazumoto Iijima
Kidney Res Clin Pract. 2020;39(4):402-413.   Published online 2020 Nov 20     DOI: https://doi.org/10.23876/j.krcp.20.111
Citations to this article as recorded by Crossref logo
The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
Tomohiko Yamamura, Tomoko Horinouchi, Yuya Aoto, Rachel Lennon, Kandai Nozu
Frontiers in Medicine.2022;[Epub]     CrossRef
A disease-causing variant of COL4A5 in a Chinese family with Alport syndrome: a case series
Jing Wu, Jun Zhang, Li Liu, Bo Zhang, Tomohiko Yamamura, Kandai Nozu, Masafumi Matsuo, Jinghong Zhao
BMC Nephrology.2021;[Epub]     CrossRef